These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20164800

  • 1. Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A.
    Chien KH, Lu DW, Chen YH, Cheng JH, Chen JT.
    J Glaucoma; 2010; 19(8):546-50. PubMed ID: 20164800
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A, Bagnato S, Boccagni C, Romano MC, Galardi G.
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [Abstract] [Full Text] [Related]

  • 3. Angle-closure glaucoma following periorbital botulinum toxin injection.
    Zheng L, Azar D.
    Clin Exp Ophthalmol; 2014 Jul; 42(7):690-3. PubMed ID: 24373149
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
    Lam DS, Leung DY, Tham CC, Li FC, Kwong YY, Chiu TY, Fan DS.
    Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064
    [Abstract] [Full Text] [Related]

  • 5. Acute Angle Closure Glaucoma (AACG): an important differential diagnosis for acute severe headache.
    Renton BJ, Bastawrous A.
    Acute Med; 2011 Jul; 10(2):77-8. PubMed ID: 22041605
    [Abstract] [Full Text] [Related]

  • 6. Refractory acute angle-closure glaucoma with retinal ischemia: January consultation #1.
    Samuelson TW.
    J Cataract Refract Surg; 2016 Jan; 42(1):173; discussion 178-9. PubMed ID: 26948794
    [No Abstract] [Full Text] [Related]

  • 7. Unusual presentation of angle-closure glaucoma treated by phacoemulsification.
    Wang JK, Lai PC.
    J Cataract Refract Surg; 2004 Jun; 30(6):1371-3. PubMed ID: 15177620
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [Abstract] [Full Text] [Related]

  • 9. Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma.
    Teekhasaenee C, Ritch R.
    Ophthalmology; 1999 Apr; 106(4):669-74; discussion 674-5. PubMed ID: 10201585
    [Abstract] [Full Text] [Related]

  • 10. Unusual presentation of angle-closure glaucoma treated by phacoemulsification.
    Tham CC, Leung DY, Lai JS, Lam DS.
    J Cataract Refract Surg; 2005 Aug; 31(8):1477-8; author reply 1478. PubMed ID: 16129262
    [No Abstract] [Full Text] [Related]

  • 11. Recurrent angle-closure glaucoma.
    Ritch R, Aung T, Lam DS.
    J Glaucoma; 2009 Sep; 18(7):567-70. PubMed ID: 19745673
    [No Abstract] [Full Text] [Related]

  • 12. Angle closure glaucoma: a cause for bilateral visual threat.
    Shakya S, Gupta HR.
    Nepal Med Coll J; 2006 Sep; 8(3):153-5. PubMed ID: 17203819
    [Abstract] [Full Text] [Related]

  • 13. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A.
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [Abstract] [Full Text] [Related]

  • 14. Follow-up of primary angle closure suspects after laser peripheral iridotomy using ultrasound biomicroscopy and A-scan biometry for a period of 2 years.
    Ramani KK, Mani B, George RJ, Lingam V.
    J Glaucoma; 2009 Sep; 18(7):521-7. PubMed ID: 19745666
    [Abstract] [Full Text] [Related]

  • 15. Detection of primary angle closure using anterior segment optical coherence tomography in Asian eyes.
    Nolan WP, See JL, Chew PT, Friedman DS, Smith SD, Radhakrishnan S, Zheng C, Foster PJ, Aung T.
    Ophthalmology; 2007 Jan; 114(1):33-9. PubMed ID: 17070597
    [Abstract] [Full Text] [Related]

  • 16. Comparison of microneedle fractional radiofrequency therapy with intradermal botulinum toxin a injection for periorbital rejuvenation.
    Jeon IK, Chang SE, Park GH, Roh MR.
    Dermatology; 2013 Jan; 227(4):367-72. PubMed ID: 24280617
    [Abstract] [Full Text] [Related]

  • 17. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [Abstract] [Full Text] [Related]

  • 18. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
    Aung T, Chan YH, Chew PT, EXACT Study Group.
    Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562
    [Abstract] [Full Text] [Related]

  • 19. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
    Kharkar S, Ambady P, Venkatesh Y, Schwartzman RJ.
    Pain Physician; 2011 Feb; 14(5):419-24. PubMed ID: 21927045
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D.
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.